Next, we used the CD31 antibody to detect the effect of OV therapy on microvasculature in tumor tissues and found that VVL-TD-mIL-27 decreased the microvascular density in the TME compared with PBS and VVL-TD-RFP at days 12 and 19. This evidence concerns the gene PECAM1 and neoplasm.